Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...

A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Limiting time spent watching television to no more than one hour each day may lower the risk of heart attack, stroke and ...

New research by the FINEXT-BD data has found that individuals suffering from bipolar disorder are at an increased risk of ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Top 20 percent income earners with college degrees have the lowest prevalence of adverse cardiovascular disease (CVD) ...

Medically reviewed by Jeffrey S. Lander, MD Hypertension (high blood pressure) can lead to dangerous complications, but it ...

Moderate exercise lowers mortality risk, but higher activity levels offer no extra benefit. Biological aging accelerates in ...